Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,525
  • Shares Outstanding, K 13,782
  • Annual Sales, $ 42,600 K
  • Annual Income, $ -12,810 K
  • 60-Month Beta 0.86
  • Price/Sales 0.77
  • Price/Cash Flow N/A
  • Price/Book 1.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +23.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.74 +35.63%
on 11/08/19
2.58 -8.57%
on 12/05/19
+0.14 (+6.31%)
since 11/06/19
3-Month
1.50 +57.33%
on 09/25/19
2.58 -8.57%
on 12/05/19
-0.17 (-6.72%)
since 09/06/19
52-Week
1.50 +57.33%
on 09/25/19
5.69 -58.52%
on 05/29/19
-2.16 (-47.79%)
since 12/06/18

Most Recent Stories

More News
Companies Strive to Tackle Ocular Diseases as Rates of Incidences Grow

There is an alarming increase in the frequency of eye-related diseases, particularly in developed countries, which in turn is expected to drive the growth of the global retinal drugs market. There are...

OPHT : 1.39 (-0.71%)
AMBS : 0.0176 (+0.57%)
AGTC : 2.87 (-3.69%)
ISEE : 4.40 (+2.33%)
EYEN : 3.55 (-4.31%)
IRIX : 2.36 (-1.26%)
Iridex: 3Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Thursday reported a loss of $1.8 million in its third quarter.

IRIX : 2.36 (-1.26%)
IRIDEX Announces 2019 Third Quarter Financial Results

IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2019.

IRIX : 2.36 (-1.26%)
IRIDEX to Present at the 2019 Stifel Healthcare Conference

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York City.

IRIX : 2.36 (-1.26%)
Will Iridex (IRIX) Report Negative Earnings Next Week? What You Should Know

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRIX : 2.36 (-1.26%)
IRIDEX Announces Appointment of Robert Gunst as Chairman of the Board of Directors and Departure of Lead Independent Director, Ruediger Naumann-Etienne

IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019. Concurrent with this appointment, Ruediger Naumann-Etienne departed...

IRIX : 2.36 (-1.26%)
IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2019 after the close of trading on Thursday, November 7, 2019. The Company's management...

IRIX : 2.36 (-1.26%)
U.S. Laser Stocks Run as China Watches

U.S. Laser Stocks Run as China Watches

LITE : 72.08 (-0.04%)
IRIX : 2.36 (-1.26%)
CUTR : 37.47 (+1.02%)
Ophthalmic Lasers Market Latest In-Depth Report Segment by Manufacturers, Type, Applications and Dynamics

A recent report provides crucial insights along with application based and forecast information in the Global Ophthalmic Lasers Market. The report provides a comprehensive analysis of key factors that...

ABT : 85.48 (+0.28%)
ELXMF : 0.3800 (-9.52%)
IRIX : 2.36 (-1.26%)
NVS : 92.07 (+0.47%)
QUTEF : 16.3561 (+1.72%)
TOPCF : 13.0700 (+1.42%)
VRX.TO : 30.80 (-3.33%)
The Zacks Industry Rank Highlights: Lumentum, Cuter and Iridex

The Zacks Industry Rank Highlights: Lumentum, Cuter and Iridex

CUTR : 37.47 (+1.02%)
IRIX : 2.36 (-1.26%)
LITE : 72.08 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade IRIX with:

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

2nd Resistance Point 2.60
1st Resistance Point 2.48
Last Price 2.36
1st Support Level 2.30
2nd Support Level 2.24

See More

52-Week High 5.69
Fibonacci 61.8% 4.09
Fibonacci 50% 3.60
Fibonacci 38.2% 3.10
Last Price 2.36
52-Week Low 1.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar